Apogee Therapeutics, Inc. (APGE) — Operating Income

Annual figures by fiscal year, from SEC filings.

2023: -$93.00M2024: -$216.87M2025: -$285.60M-$285.60M
2023Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$285.60M-31.7%
2024-$216.87M-133.2%
2023-$93.00M